Abstract
Epithelial cadherin (E-CD) is a member of the cadherin family of cell adhesion molecules and has been implicated as an invasion suppressor molecule in vitro and in vivo. We analysed 174 breast tumours from the Nottingham/Tenovus Breast Cancer Series immunohistochemically for E-CD expression using the mouse monoclonal antibody HECD-1 (Zymed Laboratories Inc.). In normal epithelial cells E-CD was strongly expressed at cell–cell boundaries. 66% of the breast cancers examined had reduced intensity of E-CD expression with 74% having significant reductions in the proportion of E-CD-positive tumour cells. Using a combined intensity/proportion score, significant associations were found between E-CD expression and tumour type (P ≤ 0.001). ER status (P = 0.026) and histological grade (P = 0.031). Expression of E-CD was not found to be related to recurrence, distant metastases, lymph node stage, vascular invasion, primary tumour size, prognostic group or survival. Thus E-CD expression in human breast cancer appears to have minimal prognostic value, but may have a role as a phenotypic marker. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Becker KF, Reich U, Schott C, Becker I, Berx G, van Roy F and Hofler H (1999) Identification of eleven novel tumour-associated E-cadherin mutations. Mutations in brief no. 215. Online. Human Mutations 13: 171
Behrens J (1993) The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat 24: 175–184
Berx G, Cleton-Jansen AM and Strumane K (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13: 1919–1925
Birchmeier W and Beherns J (1994) Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11–26
Bracke ME, Charlier C, Bruyneel EA, Labit C, Mareel MM and Castronovo V (1994) Tamoxifen restores the E-Cadherin function in Human Breast Cancer MCF-7/6 Cells and Suppresses Their Invasive Phenotype. Cancer Research 54: 4607–4609
Bussemakers MJG, Giroldi LA, Van Bokhoven A and Schalken JA (1994) Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: Characterisation of the human E-Cadherin gene promoter. Biochem Biophy Res Comm 203(2): 1284–1291
Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R and Lavaut M (1997) E-Cadherin quantitative immunocytochemical assays in breast carcinomas. J of Path 181: 294–300
Doroudi S, Sheffield JP, Poulsom R, Northover JMA and Hart IR (1993) E-Cadherin expression in colorectal cancer: An immunocytochemical and In Situ hybridisation study. Am J of Pathol 142: 981–986
Ellis IO, Galea M, Broughton N, Locker A, Blamey RW and Elston CW (1992) Pathological prognostic factors in breast cancer. II. Histological types. Relationship with survival in a large study with long term follow up. Histopathology 20: 479–489
Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403–410
Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A (1993) Correlation of E-cadherin expression with differentiation grade and histological type in breast cancer. Am J of Pathol 142: 987–993
Gonzalez MA, Pinder SE, Wencyk P, Bell JA, Elston CW, Nicholson RI, Robertson JFR, Blamey RW and Ellis IO (1999) An immunohistochemical examination of the expression of E-Cadherin, a-and b/y -Catenins, and a2 and b1-Integrins in invasive breast cancer. J of Pathol 187: 523–529
Gupta SK, Douglas-Jones AG, Jasani B, Moragn JM, Pignatelli M and Mansel RE (1997) E-Cadherin expression in duct carcinoma In Situ (DCIS) of the breast. Virchows Archives 430: 23–28
Hashizume R, Koizumi H, Ihara A, Ohta T and Uchikoshi T (1996) Expression of β-catenin in normal breast tissue and breast carcinoma: A comparative study with epithelial cadherin and α-catenin. Histopathology 29: 139–146
Hiraguri S, Godfrey T and Nakamura H et al (1998) Mechanisms of inactivation of E-Cadherin in breast cancer cell lines. Cancer Res 58: 1972–1977
Hunt NCA, Douglas-Jones AG, Jasani B, Morgan JM and Pignatelli M (1997) Loss of E-Cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Archives 430: 285–289
Kemler R (1993) From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends in Genetics 9(9): 317–321
Lee SM (1996) H-Cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nature Medicine 2(7): 776–782
Lipponen P, Saarelainen E, Ji H, Aaltomaa S and Syrjanen K (1994) Expression of E-Cadherin as related to other prognostic factors and survival in breast cancer. J of Pathol 174: 101–109
Maguire TM, Shering SG, McDermott EW, O’Higgins N, Fenelly JJ, Crown J and Duffy MJ (1997) Assay of E-Cadherin by ELISA in Human Breast Cancers. European J of Cancer 33(3): 404–408
Mareel MM, Behrens J, Birchmeier W, De Bruyne G, Vleminikx K, Hoogewus A, Fiers W and Van Roy FM (1991) Down-regulation of E-Cadherin expression in madin darby canine kidney cells inside tumours of nude mice. Intern J of Cancer 47: 922–928
Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W and Funke I (1993) E-Cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Research 53: 1690–1695
Meiners S, Brinkmann V, Naundorf H and Birchmeier W (1998) Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16: 9–20
Moll R, Mitze M, Frixen UH and Birchmeier W (1993) Differential loss of E-Cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J of Pathol 143: 1731–1742
Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M and Mori T (1993) Expression of E-Cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Research 53: 1696–1701
Pererria H, Pinder SE and Sibbering DM et al (1995) Pathological prognostic factors in breast cancer IV. Should you be a typer or grader? A comparative study of two prognostic variables in operable breast cancer. Histopathology 27: 219–226
Perl A-K, Wilgenbus P, Dahl U, Semb H and Christofori G (1998) A causal role for E-Cadherin in the transition from adenoma to carcinoma. Nature 392: 190–193
Pinder SE, Ellis IO, Galea M, O’Rouke S, Blamey RW and Elston CW (1994) Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 24: 41–47
Pizarro A, Benito N, Navarro P, Palacios J, Cano A, Quintanilla M, Contreras F and Gamallo C (1994) E-Cadherin expression in basal cell carcinoma. Brit J of Cancer 69: 157–162
Rasbridge SA, Gillet CE, Sampson SA, Walsh FS and Millis RR (1993) Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J of Pathol 169: 245–250
Rimm DL, Sinard JH and Morrow JS (1995) Reduced α-catenin and E-cadherin expression in breast cancer. Laboratory Investigation 72, (5): 506–512
Royal College of Pathologists’ Working Group (1991) Pathology reporting in breast cancer screening. J Clin Path 44: 710–725
Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W (1991) E-Cadherin expression in squamous cell carcinomas of the head and neck: inverse correlation with tumour dedifferentiation and lymph node metastasis. Cancer Research 51: 6328–6337
Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S and Hirohashi S (1992) Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Research 52: 5770–5774
Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA and Isola JJ (1996) Reduced E-Cadherin expression is associated with invasiveness and unfavourable prognosis in breast cancer. Am J of Cli Patho 105: 394–402
Van der Wurff AAM, Kate JT, Van der Linden EPM, Dinjens WNM, Arends J-W and Bosman FT (1992) L-CAM expression in normal. Premalignant and malignant colon mucosa. J of Pathol 168: 287–291
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Parker, C., Rampaul, R., Pinder, S. et al. E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 85, 1958–1963 (2001). https://doi.org/10.1054/bjoc.2001.2178
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2178
Keywords
This article is cited by
-
TGFα-EGFR pathway in breast carcinogenesis, association with WWOX expression and estrogen activation
Journal of Applied Genetics (2022)
-
Immunohistochemical E-cadherin Expression and Response to Chemotherapy in Breast Cancer Subjects
Indian Journal of Surgery (2021)
-
Retrospective analysis of metastatic behaviour of breast cancer subtypes
Breast Cancer Research and Treatment (2015)
-
Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
BMC Cancer (2014)
-
Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
BMC Veterinary Research (2014)